China Cord Blood Corporation to partner with Cordlife Group
China | News | By BioSpectrum Bureau | 0 Comment | 17 Aug, 2012
Singapore: China Cord Blood Corporation (CCBC), the first and largest cord blood banking operator in China, and Cordlife...Read more
WuXi genomics lab gets CLIA certification
China | News | By BioSpectrum Bureau | 0 Comment | 18 Oct, 2013
Singapore: WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with ...Read more
DHL expands secure cold chain network
China | News | By BioSpectrum Bureau | 0 Comment | 18 Apr, 2013
Singapore: DHL Global Forwarding, the air and ocean freight specialist, has expanded its Qualified Envirotainer Provider...Read more
NovaBay, China Pioneer announce expansion plans
China | News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2013
Singapore: Clinical-stage biopharmaceutical company, NovaBay Pharmaceuticals, announced that it has expanded its NeutroP...Read more
Sinovac reports unaudited Q2 financial results
China | Company results | By BioSpectrum Bureau | 4 Comment | 16 Aug, 2012
Singapore: Sinovac Biotech, a leading provider of biopharmaceutical products in China, published its unaudited second qu...Read more
F&S: China pharma market to touch $280 bn by 2016
China | Analysis | By BioSpectrum Bureau | 0 Comment | 29 May, 2013
Singapore: China pharmaceutical market has earned revenue of $131.63 billion in 2012 and this will more than double to $...Read more
Medical tourism market to reach $32.5 bn globally in 2019: Report
China | News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2013
Singapore: The global medical tourism market was valued at $10.5 billion in 2012 and is estimated to reach a market wort...Read more
Boston Scientific opens IAS, innovation center in Shanghai
China | News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013
Singapore: Reinforcing its ongoing commitment to leadership in the global medical technology market, Boston Scientific h...Read more
China now probes Bayer for unfair competition
China | News | By BioSpectrum Bureau | 0 Comment | 16 Sep, 2013
Singapore: Chinese authorities led by a local branch of China's State Administration for Industry and Commerce (SAIC) vi...Read more
Biostar to establish call center for new B2C platform
China | News | By BioSpectrum Bureau | 0 Comment | 09 Aug, 2012
Singapore: Biostar Pharmaceuticals, a PRC-based manufacturer and marketer of pharmaceutical and health supplement produ...Read more
Biomaterials market will be worth $88.4 bn by 2017
China | Analysis | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2013
Singapore: A new report by MarketsAndMarkets titled 'Biomaterials market and applications - Global forecasts to 2017', e...Read more
Medtronic to acquire China Kanghui for $816 mn in cash
China | News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2012
Singapore: Medtronic and China Kanghui Holdings have entered into a merger agreement whereby Medtronic will acquire Kang...Read more
Simcere appoints Dr. Zang Jingwu as CSO
China | Influencers | By BioSpectrum Bureau | 0 Comment | 17 Oct, 2013
Singapore: China based Simcere Pharmaceutical has appointed Dr. Zang Jingwu as Chief Scientific Officer, effective Octob...Read more
BioSpectrum Asia launches 5th CRO survey
China | News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2013
Singapore: After four consecutive successful annual surveys on the developments in the clinical research industry, BioSp...Read more
OriGene to acquire SDIX life science assets
China | News | By BioSpectrum Bureau | 0 Comment | 15 Apr, 2013
Singapore: OriGene Technologies, genome wide product company for research and diagnostic applications, acquired all the ...Read more
Commercial data imperatives for pharma in China
China | Opinion | By BioSpectrum Bureau | 0 Comment | 25 Oct, 2013
As Chinese pharma moves forward to become the second largest market in the world by 2015, commercial operations for the ...Read more
Chinese experts call for stem cell regulation
China | Regulatory | By BioSpectrum Bureau | 2 Comment | 20 Jun, 2013
Singapore: Life science experts in China have called for more effective regulation in the domain of stem cell treatments...Read more
Pharmacovigilance: A strategic opportunity
China | Opinion | By BioSpectrum Bureau | 2 Comment | 06 Sep, 2012
For many Asian pharmaceutical companies, pharmacovigilance is a critical component of any drug development program. As p...Read more